KALA BIO, Inc. — Form D

KALA BIO, Inc. of ARLINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-04-13. The offering totals $67.9M, of which $67.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (44)

Showing 25 of 44 people.

NameRoleLocation
Kevin BittermanDirectorCambridge, MA
Greg GrunbergDirectorLawrence, MA
Robert LangerDirectorPittsburgh, PA
Robert PaullDirectorBoston, MA
Rajeev B ShahDirectorWaltham, MA
Robert TepperDirectorCambridge, MA
Chen B YuDirectorWaltham, MA
Hongming B ChenExecutive OfficerWaltham, MA
Charles B McDermottExecutive OfficerWaltham, MA
Andrew L KovenDirectorCambridge, MA
David LazarDirectorARLINGTON, MA
Darius KharabiExecutive OfficerArlington, MA
Todd BazemoreExecutive OfficerFRAMINGHAM, MA
Gregory D PerryDirectorArlington, MA
Marjan D FaridDirectorArlington, MA
Mark IwickiDirectorArlington, MA
Mark IwickiExecutive OfficerArlington, MA
Mary ReumuthExecutive OfficerArlington, MA
C. Daniel MyersDirectorArlington, MA
Kim BrazzellExecutive OfficerArlington, MA
Brendan PurdyDirectorArlington, MA
Mark S BlumenkranzDirectorArlington, MA
PETER COUROSSIExecutive OfficerChicago, IL
Howard B RosenDirectorSan Mateo, CA
Darius Daniel KharabiExecutive OfficerWatertown, MA

Other filings by this issuer (11)

FiledFormOfferingSold
2026-03-17D$1.8M$1.8M
2026-02-13D$4.2M$2.3M
2024-12-31D$10.7M$10.7M
2024-06-28D$12.5M$12.5M
2021-11-29D$36.5M$16.1M
2015-08-19D$7.0M$7.0M
2014-04-24D$22.5M$22.5M
2013-02-28D$11.5M$5.8M
2012-03-14D$7.2M$7.2M
2010-11-10D$3.0M$3.0M
2009-12-23D$2.0M$2.0M

More